JP2019507736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507736A5 JP2019507736A5 JP2018539149A JP2018539149A JP2019507736A5 JP 2019507736 A5 JP2019507736 A5 JP 2019507736A5 JP 2018539149 A JP2018539149 A JP 2018539149A JP 2018539149 A JP2018539149 A JP 2018539149A JP 2019507736 A5 JP2019507736 A5 JP 2019507736A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- pharmaceutical composition
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@@](C=CC(C)=CN=*)(C=NCC=C*)[Rn] Chemical compound C[C@@](C=CC(C)=CN=*)(C=NCC=C*)[Rn] 0.000 description 4
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022062494A JP2022088620A (ja) | 2016-01-27 | 2022-04-04 | 掻痒の処置のためのｇａｂａａ受容体モジュレーターの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16153035 | 2016-01-27 | ||
| EP16153035.7 | 2016-01-27 | ||
| EP16178824 | 2016-07-11 | ||
| EP16178824.5 | 2016-07-11 | ||
| PCT/EP2017/051866 WO2017129801A1 (en) | 2016-01-27 | 2017-01-27 | Use of gabaa receptor modulators for treatment of itch |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022062494A Division JP2022088620A (ja) | 2016-01-27 | 2022-04-04 | 掻痒の処置のためのｇａｂａａ受容体モジュレーターの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507736A JP2019507736A (ja) | 2019-03-22 |
| JP2019507736A5 true JP2019507736A5 (enExample) | 2020-03-05 |
| JP7115746B2 JP7115746B2 (ja) | 2022-08-09 |
Family
ID=57890845
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018539149A Active JP7115746B2 (ja) | 2016-01-27 | 2017-01-27 | 掻痒の処置のためのｇａｂａａ受容体モジュレーターの使用 |
| JP2022062494A Pending JP2022088620A (ja) | 2016-01-27 | 2022-04-04 | 掻痒の処置のためのｇａｂａａ受容体モジュレーターの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022062494A Pending JP2022088620A (ja) | 2016-01-27 | 2022-04-04 | 掻痒の処置のためのｇａｂａａ受容体モジュレーターの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10786513B2 (enExample) |
| EP (1) | EP3407886A1 (enExample) |
| JP (2) | JP7115746B2 (enExample) |
| KR (1) | KR102482200B1 (enExample) |
| CN (1) | CN108697694B (enExample) |
| AU (1) | AU2017213154B2 (enExample) |
| BR (1) | BR112018015386A2 (enExample) |
| CA (2) | CA3012791C (enExample) |
| CL (1) | CL2018002023A1 (enExample) |
| IL (1) | IL260775B (enExample) |
| MX (1) | MX388862B (enExample) |
| SG (1) | SG11201806393QA (enExample) |
| UA (1) | UA125463C2 (enExample) |
| WO (1) | WO2017129801A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX388862B (es) | 2016-01-27 | 2025-03-20 | Univ Zuerich | Uso de moduladores de receptores de gabaa para el tratamiento de picor. |
| JP7449272B2 (ja) | 2018-04-18 | 2024-03-13 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| EP3796907A4 (en) | 2018-05-22 | 2021-11-03 | Neurocycle Therapeutics, Inc. | GABAA POSITIVE ALLOSTERIC MODULATING COMPOUNDS FOR THE TREATMENT OF PRURITUS AND / OR DERMATITIS |
| LT3849976T (lt) | 2018-09-13 | 2023-02-10 | Saniona A/S | Gaba a receptoriaus ligandas |
| CA3132810A1 (en) * | 2019-03-18 | 2020-09-24 | Neurocycle Therapeutics, Inc. | Use of gabaa receptor modulators for treatment of fybromyalgia |
| CN110004118B (zh) * | 2019-03-29 | 2023-03-28 | 中国科学院武汉物理与数学研究所 | 用于辅助重组狂犬病毒在神经细胞高效逆向跨单级突触的rAAV病毒的包装方法及其应用 |
| CA3155618A1 (en) * | 2019-10-23 | 2021-04-29 | Jed Hubbs | Treatment of epileptic conditions with gabaa receptor modulators |
| US12233070B2 (en) * | 2020-06-30 | 2025-02-25 | University Of Mississippi Medical Center | Methods for treating benzodiazepine misuse/use disorder |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1024526A (en) | 1911-07-25 | 1912-04-30 | George R Schweikert | Chair. |
| IL127911A0 (en) | 1996-07-25 | 1999-11-30 | Merck Sharp & Dohme | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| FR2767692B1 (fr) * | 1997-09-01 | 2000-03-03 | Oreal | Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles |
| GB9813576D0 (en) | 1998-06-24 | 1998-08-19 | Merck Sharp & Dohme | Therapeutic agents |
| GB9903119D0 (en) * | 1999-02-11 | 1999-04-07 | Merck Sharp & Dohme | Therapeutic agents |
| JP4302980B2 (ja) | 2000-11-10 | 2009-07-29 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体リガンドとしてのイミダゾ−トリアジン誘導体 |
| GB0117277D0 (en) | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
| TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| KR100865410B1 (ko) | 2002-03-28 | 2008-10-24 | 위시스 테크놀로지 파운데이션, 인크. | 진정 및 운동실조 효과가 감소된 항불안제 |
| US8835424B2 (en) | 2002-03-28 | 2014-09-16 | Wisconsin Alumni Research Foundation | Selective agents for pain suppression |
| GB0210124D0 (en) | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| JP2004170323A (ja) * | 2002-11-22 | 2004-06-17 | Sumitomo Pharmaceut Co Ltd | 皮膚疾患治療剤のスクリーニング方法 |
| JPWO2005030773A1 (ja) * | 2003-09-26 | 2006-12-07 | 大日本住友製薬株式会社 | 新規ピラゾロピリミジン誘導体 |
| WO2005108401A1 (en) * | 2004-04-29 | 2005-11-17 | Dov Pharmaceutical, Inc. | 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
| WO2006061428A2 (en) * | 2004-12-10 | 2006-06-15 | Universität Zürich | Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| KR20060087386A (ko) * | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
| PT2054416E (pt) | 2006-08-04 | 2011-04-06 | Merz Pharma Gmbh & Co Kgaa | Pirazolopirimidinas substituídas, um processo para a sua preparação e a sua utilização como medicamento |
| EP2497470B8 (en) | 2006-11-22 | 2015-12-02 | Incyte Holdings Corporation | Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| WO2009021957A2 (en) * | 2007-08-14 | 2009-02-19 | Novartis Ag | Tricyclic heterocyclic compounds as gaba a modulators |
| NZ589622A (en) | 2008-05-21 | 2012-10-26 | Incyte Corp | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| WO2010063487A1 (en) | 2008-12-05 | 2010-06-10 | Merz Pharma Gmbh & Co. Kgaa | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| RU2549547C2 (ru) | 2009-04-22 | 2015-04-27 | Янссен Фармацевтика Нв | Азетидинилдиамиды в качестве ингибиторов моноацилглицерин-липазы |
| EP2456311A4 (en) | 2009-07-24 | 2013-01-23 | Concert Pharmaceuticals Inc | SUBSTITUTED IMIDASOTRIAZINES |
| WO2012026766A2 (ko) * | 2010-08-25 | 2012-03-01 | (주)네오팜 | 신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물 |
| US20130331394A1 (en) | 2012-06-11 | 2013-12-12 | The Mclean Hospital Corporation | Treating schizophrenia |
| MX353336B (es) * | 2013-02-19 | 2018-01-09 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa del receptor de tropomiosina (trk). |
| WO2015072853A1 (en) * | 2013-11-13 | 2015-05-21 | Rjg Developments B.V. | Treatment of herpes virus infection outbreaks |
| GB201321732D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| US9844551B2 (en) | 2015-01-14 | 2017-12-19 | Children's Hospital Medical Center | Compositions and methods for treatment of fragile X syndrome |
| WO2016154031A1 (en) | 2015-03-20 | 2016-09-29 | Uwm Research Foundation, Inc. | Gabaergic ligands and their uses |
| MX388862B (es) | 2016-01-27 | 2025-03-20 | Univ Zuerich | Uso de moduladores de receptores de gabaa para el tratamiento de picor. |
-
2017
- 2017-01-27 MX MX2018009252A patent/MX388862B/es unknown
- 2017-01-27 CA CA3012791A patent/CA3012791C/en active Active
- 2017-01-27 EP EP17701549.2A patent/EP3407886A1/en active Pending
- 2017-01-27 WO PCT/EP2017/051866 patent/WO2017129801A1/en not_active Ceased
- 2017-01-27 JP JP2018539149A patent/JP7115746B2/ja active Active
- 2017-01-27 CA CA3222584A patent/CA3222584A1/en active Pending
- 2017-01-27 KR KR1020187022974A patent/KR102482200B1/ko active Active
- 2017-01-27 BR BR112018015386-9A patent/BR112018015386A2/pt not_active IP Right Cessation
- 2017-01-27 UA UAA201808382A patent/UA125463C2/uk unknown
- 2017-01-27 SG SG11201806393QA patent/SG11201806393QA/en unknown
- 2017-01-27 CN CN201780008490.1A patent/CN108697694B/zh not_active Expired - Fee Related
- 2017-01-27 AU AU2017213154A patent/AU2017213154B2/en not_active Expired - Fee Related
-
2018
- 2018-07-25 US US16/045,193 patent/US10786513B2/en active Active
- 2018-07-25 IL IL260775A patent/IL260775B/en unknown
- 2018-07-26 CL CL2018002023A patent/CL2018002023A1/es unknown
-
2020
- 2020-08-14 US US16/994,146 patent/US11529359B2/en active Active
-
2022
- 2022-04-04 JP JP2022062494A patent/JP2022088620A/ja active Pending
- 2022-09-01 US US17/901,356 patent/US12433898B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019507736A5 (enExample) | ||
| RU2344123C9 (ru) | 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора | |
| CA2659425C (en) | Triazole compounds that modulate hsp90 activity | |
| AU2006214164B2 (en) | Isoxazole combretastin derivatives for the treatment of disorders | |
| CN105218523B (zh) | 吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用 | |
| RU2363700C2 (ru) | Производные хинуклидина и фармацевтические композиции, содержащие их | |
| US20200069681A1 (en) | Cannabinoid receptor modulators | |
| RU2016137832A (ru) | Соединения для лечения опосредованных комплементом нарушений | |
| CN105130959B (zh) | 嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用 | |
| CN105254624B (zh) | 异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用 | |
| JP2013502431A5 (enExample) | ||
| US8680100B2 (en) | Sulfonylhydrazide compounds for treating proliferative disorders | |
| JP2021512055A5 (enExample) | ||
| CA2903288A1 (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| RU2016137263A (ru) | Соединение триазина и его применение в медицинских целях | |
| JP2020533352A5 (enExample) | ||
| JP2014515735A5 (enExample) | ||
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| JP2014506582A5 (enExample) | ||
| RU2007107494A (ru) | Трициклические производные инденопиррола как модуляторы серотининовых рецепторов, фармацевтическая композиция на их основе и способ лечения заболеваний, растройств и/или патологических состояний, связанных с необходимостью модуляции функции 5-нт2с рецепторов | |
| JP7247106B2 (ja) | 内臓痛の治療のための化合物および方法 | |
| JP2015500267A5 (enExample) | ||
| AU2006318709B2 (en) | Thiazoles for the treatment of proliferative disorders | |
| JP2015516001A5 (enExample) | ||
| JP2013532146A5 (enExample) |